Lescol Mr (Fluvastatin Sodium)

Fluvastatin inhibits the hepatic enzyme HMG‑CoA reductase, the rate‑limiting step in cholesterol synthesis. This decreases cholesterol production, up‑regulates LDL receptors, and enhances removal of LDL from the bloodstream.

The dosage of Lescol MR is individualized by the prescribing healthcare professional based on the patient’s lipid profile, cardiovascular risk, and tolerability. The prescriber determines the appropriate strength and dosing schedule, which may be adjusted during therapy.

Safety of fluvastatin during pregnancy and lactation has not been established. It is generally contraindicated in pregnant women because of potential teratogenic effects, and breastfeeding is not recommended unless a physician determines that the benefits outweigh the risks.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lescol MR (fluvastatin) is a moderate‑intensity statin with a relatively short half‑life compared with agents such as atorvastatin or rosuvastatin. It may be preferred in patients who need modest LDL‑cholesterol reductions or who have experienced intolerance to higher‑potency statins, though individual response varies.

Lescol MR tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Lescol MR is taken orally, usually once daily in the evening, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew the modified‑release formulation.

The most serious adverse reactions include rhabdomyolysis, severe liver injury, and hypersensitivity reactions such as Stevens‑Johnson syndrome. Patients should promptly report unexplained muscle pain, weakness, dark urine, or signs of liver dysfunction such as jaundice.

Lescol MR is contraindicated in patients with active liver disease, unexplained persistent elevations of serum transaminases, known hypersensitivity to fluvastatin or any excipients, and in women who are pregnant or may become pregnant without appropriate contraception. Caution is also advised in severe renal impairment.